Press release -

Cambio Ltd. appointed as distributor in United Kingdom

Halo Genomics will work in partnership with Cambio Ltd. to introduce the Selector product line for targeted resequencing to the British market. Cambio Ltd is a privately held UK company, established over 25 years ago, with an excellent reputation for the supply of quality molecular biology reagents and consumables for the life science market.

Commenting on the agreement, Maria Hjortsmark, Chief Business Officer said, “UK is an important market for us, so it was vital that we found the right partner. Cambio has the technical expertise to provide high quality product support to next generation sequencing core facilities.”

Dr Peter Dean, Chairman of Cambio Ltd said, “Selector Target Enrichment Kit is an excellent addition to our current Next Generation Sequencing product portfolio. We are excited to bring this innovative technology to our market place”.

Related links

Topics

  • Science, technology

Categories

  • next generation sequencing (ngs).
  • cancer exon sequencing
  • genetic testing
  • genetic disorders and treatments
  • sample enrichment
  • sample preparation
  • target enrichment
  • targeted resequencing
  • biotechnology

Halo Genomics is a provider of innovative technology for sample preparation in next generation sequencing. Halo Genomics was founded by scientists from Uppsala University and Olink AB. Based in Uppsala, Sweden, the company's solutions are offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.

Contacts

Olle Ericsson

Press contact CEO, Co-founder +46 18 495 31 20

Related media

Cambio Ltd. appointed as distributor in United Kingdom
  • Cambio Ltd. appointed as distributor in United Kingdom
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Related content

Integrated Sciences Pty Ltd. appointed as distributor in Australia and New Zealand

UPPSALA, Sweden, February 24, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced the appointment of Integrated Sciences Pty. as its distributor in Australia and New Zealand.

Biozym Scientific GmbH will distribute Halo Genomics’ products in Germany and Austria

UPPSALA, Sweden, March 7, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced its newest distribution partner, Biozym Scientific GmbH.

Halo Genomics appoints Westburg B.V. as the distributor in Benelux

UPPSALA, Sweden, March 21, 2011 – Halo Genomics AB, a company providing products for next generation targeted sequencing, today announced that it has appointed Westburg B.V. as distributor in Belgium, the Netherlands and Luxemburg.

Halo Genomics appoints South Korean distributor

UPPSALA, Sweden, March 24, 2011 – Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced the appointment of Molecular Diagnostics Korea Inc. (MDxK) as its Korean distributor.

Halo Genomics expands its European distributor network

UPPSALA, Sweden, May 27, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, today announced the appointment of Ozyme as its distributor in France.

Halo Genomics signs Japanese distributor

UPPSALA, Sweden, June 16, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, announces the appointment of Nacalai Tesque, Inc. as its Japanese distributor.

Genycell Biotech appointed as distributor in Spain & Portugal

Sweden, July 27, 2011 – Halo Genomics AB, a company providing products for next generation targeted resequencing, today announced the appointment of Genycell Biotech Spain SL as its distributor in Spain and Portugal.